Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amy Wehn"'
Autor:
Justin, Waller, Lin, Gu, Amanda M, De Hoedt, Stephen J, Freedland, Tongtong, Wang, Mayur, Amonkar, Deepti, Aurora-Garg, Kai-Li, Liaw, Amy, Wehn, Zachary, Klaassen
Publikováno v:
Future Oncology. 18:649-660
Background: Challenges in identifying microsatellite instability (MSI)/mismatch repair (MMR)-tested colorectal carcinoma (CRC) patients in electronic health records have led to gaps in the understanding of MSI-high/deficient mismatch repair prevalenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b1030a5338af2820b0d83459e96de3
https://doi.org/10.2217/fon-2021-0874
https://doi.org/10.2217/fon-2021-0874
Autor:
Aurelien Marabelle, Jeff Cesario, Lixin Lang, Deepti Aurora-Garg, Siddhartha Krishan Mathur, Diane Levitan, Deb Card, Fan Jin, David Adelberg, Thierry André, Amy Wehn
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccd8f31690ef2610ae8a7779f9becd9f
https://doi.org/10.1136/jitc-2022-sitc2022.0544
https://doi.org/10.1136/jitc-2022-sitc2022.0544
Autor:
Wilko Weichert, Ping Qiu, Jared Lunceford, Amy Wehn, Alexander Yarunin, Razvan Cristescu, Li Liu, Kyria Roessler, Kirsten Timms, Matthew John Marton
Publikováno v:
Journal of Clinical Oncology. 40:e17571-e17571
e17571 Background: Olaparib + bevacizumab is approved as first-line maintenance treatment of ovarian cancer that is HRD positive, defined as the presence of a deleterious/suspected deleterious BRCA mutation (BRCAm) and/or genomic instability. HRD gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62082393a429bc7908f9dccd36a442d6
https://doi.org/10.1200/jco.2022.40.16_suppl.e17571
https://doi.org/10.1200/jco.2022.40.16_suppl.e17571
Autor:
Tongtong Wang, Justin D. Waller, Amy Wehn, Amanda De Hoedt, Stephen J. Freedland, Mayur M. Amonkar, Lin Gu, Zachary Klaassen, Kai-Li Liaw, Deepti Aurora-Garg, Daniel Albo
Publikováno v:
Journal of Clinical Oncology. 39:e15562-e15562
e15562 Background: Microsatellite instability-high (MSI-H) and deficient mismatch repair (dMMR) cancers exhibit high mutational load and are observed in colorectal carcinomas (CRC). The objectives of this study were to determine the proportion of MSI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d6b96a3082a99ba5b51f772a5ebfa72
https://doi.org/10.1200/jco.2021.39.15_suppl.e15562
https://doi.org/10.1200/jco.2021.39.15_suppl.e15562